People: Oxford BioMedica PLC (OXB.L)
Dr. Andrew J. Heath, M.D., Ph.D., serves as Non-Executive Deputy Chairman of the Board, Senior Independent Director of Oxford BioMedica PLC. Dr Heath is a biopharmaceutical executive with in-depth knowledge of US and UK capital markets and international experience in marketing and sales, R & D and business development. He was Chief Executive Officer of Protherics plc from 1997 to 2008, taking the Company from 30 to 350 staff and managing its eventual acquisition by BTG for £220 million. Prior to this, Dr Heath held senior positions at Astra AB and Astra USA, including Vice President Marketing & Sales, and at Glaxo Sweden as Associate Medical Director.
|Total Annual Compensation, GBP||46,000|
|Restricted Stock Award, GBP||--|
|Long-Term Incentive Plans, GBP||--|
|All Other, GBP||--|
|Fiscal Year Total, GBP||46,000|